Insider · CIK 0001251371
Saundra L Pelletier
Files at TCON (Tracon Pharmaceuticals, Inc.), EVFM (Evofem Biosciences, Inc.). First filing -, latest -.
In brief
Saundra L Pelletier files SEC Form 4 as CEO and director at TCON (Tracon Pharmaceuticals, Inc.), and also at EVFM (Evofem Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Saundra L Pelletier has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 31, 2022 | EVFM Evofem Biosciences, Inc. | DDisposition to issuer Common Stock | -50,000 | $0.00 | $0 | 186,722 | Apr 26, 2023 |
| Apr 19, 2023 | TCON Tracon Pharmaceuticals, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +18,000 | $0.00 | $0 | 18,000 | Apr 21, 2023 |
Questions about Saundra L Pelletier
Answered from the filings on this page, as of the latest one.
Is Saundra L Pelletier buying or selling?
Saundra L Pelletier has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Saundra L Pelletier's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Saundra L Pelletier has 0.
Where does Saundra L Pelletier file Form 4?
Saundra L Pelletier has filed Form 4 at TCON (Tracon Pharmaceuticals, Inc.); EVFM (Evofem Biosciences, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.